Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TELA Bio (TELA) Other Operating Expenses (2018 - 2026)

TELA Bio has reported Other Operating Expenses over the past 8 years, most recently at $12.4 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $12.4 million; the TTM value through Dec 2025 reached $54.9 million, up 624.92%, while the annual FY2025 figure was $54.9 million, 624.92% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $12.4 million at TELA Bio, down from $13.1 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $17.2 million in Q4 2023 and troughed at -$20000.0 in Q2 2024.
  • A 5-year average of $10.8 million and a median of $11.4 million in 2022 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: plummeted 100.14% in 2024 and later surged 73595.0% in 2025.
  • Year by year, Other Operating Expenses stood at $8.3 million in 2021, then skyrocketed by 40.11% to $11.6 million in 2022, then skyrocketed by 47.37% to $17.2 million in 2023, then plummeted by 100.12% to -$20000.0 in 2024, then skyrocketed by 62130.0% to $12.4 million in 2025.
  • Business Quant data shows Other Operating Expenses for TELA at $12.4 million in Q4 2025, $13.1 million in Q3 2025, and $14.7 million in Q2 2025.